Literature DB >> 24596090

A proposed mechanism for the promotion of prion conversion involving a strictly conserved tyrosine residue in the β2-α2 loop of PrPC.

Timothy D Kurt1, Lin Jiang, Cyrus Bett, David Eisenberg, Christina J Sigurdson.   

Abstract

The transmission of infectious prions into different host species requires compatible prion protein (PrP) primary structures, and even one heterologous residue at a pivotal position can block prion infection. Mapping the key amino acid positions that govern cross-species prion conversion has not yet been possible, although certain residue positions have been identified as restrictive, including residues in the β2-α2 loop region of PrP. To further define how β2-α2 residues impact conversion, we investigated residue substitutions in PrP(C) using an in vitro prion conversion assay. Within the β2-α2 loop, a tyrosine residue at position 169 is strictly conserved among mammals, and transgenic mice expressing mouse PrP having the Y169G, S170N, and N174T substitutions resist prion infection. To better understand the structural requirements of specific residues for conversion initiated by mouse prions, we substituted a diverse array of amino acids at position 169 of PrP. We found that the substitution of glycine, leucine, or glutamine at position 169 reduced conversion by ∼ 75%. In contrast, replacing tyrosine 169 with either of the bulky, aromatic residues, phenylalanine or tryptophan, supported efficient prion conversion. We propose a model based on a requirement for tightly interdigitating complementary amino acid side chains within specific domains of adjacent PrP molecules, known as "steric zippers," to explain these results. Collectively, these studies suggest that an aromatic residue at position 169 supports efficient prion conversion.

Entities:  

Keywords:  Amyloid; Infectious Diseases; Neurodegenerative Diseases; Prions; Protein Aggregation; Steric Zipper; TSE; Transmissible Spongiform Encephalopathy; β2-α2 Loop

Mesh:

Substances:

Year:  2014        PMID: 24596090      PMCID: PMC4036184          DOI: 10.1074/jbc.M114.549030

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Structural plasticity of the cellular prion protein and implications in health and disease.

Authors:  Barbara Christen; Fred F Damberger; Daniel R Pérez; Simone Hornemann; Kurt Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

2.  Heparin enhances the cell-protein misfolding cyclic amplification efficiency of variant Creutzfeldt-Jakob disease.

Authors:  Takashi Yokoyama; Atsuko Takeuchi; Miyuki Yamamoto; Tetsuyuki Kitamoto; James W Ironside; Masanori Morita
Journal:  Neurosci Lett       Date:  2011-05-05       Impact factor: 3.046

3.  Scrapie prions aggregate to form amyloid-like birefringent rods.

Authors:  S B Prusiner; M P McKinley; K A Bowman; D C Bolton; P E Bendheim; D F Groth; G G Glenner
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

4.  Horse prion protein NMR structure and comparisons with related variants of the mouse prion protein.

Authors:  Daniel R Pérez; Fred F Damberger; Kurt Wüthrich
Journal:  J Mol Biol       Date:  2010-05-08       Impact factor: 5.469

5.  Prion protein NMR structures of elk and of mouse/elk hybrids.

Authors:  Alvar D Gossert; Sophie Bonjour; Dominikus A Lysek; Francesco Fiorito; Kurt Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-12       Impact factor: 11.205

Review 6.  Bovine spongiform encephalopathy and its association with the feeding of ruminant-derived protein.

Authors:  D M Taylor
Journal:  Dev Biol Stand       Date:  1993

7.  A natural case of chronic wasting disease in a free-ranging moose (Alces alces shirasi).

Authors:  Laurie A Baeten; Barbara E Powers; Jean E Jewell; Terry R Spraker; Michael W Miller
Journal:  J Wildl Dis       Date:  2007-04       Impact factor: 1.535

8.  Prion protein NMR structure from tammar wallaby (Macropus eugenii) shows that the beta2-alpha2 loop is modulated by long-range sequence effects.

Authors:  Barbara Christen; Simone Hornemann; Fred F Damberger; Kurt Wüthrich
Journal:  J Mol Biol       Date:  2009-04-23       Impact factor: 5.469

9.  A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells.

Authors:  S A Priola; B Chesebro
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor.

Authors:  James C Geoghegan; Michael B Miller; Aimee H Kwak; Brent T Harris; Surachai Supattapone
Journal:  PLoS Pathog       Date:  2009-07-31       Impact factor: 6.823

View more
  19 in total

1.  Prion protein β2-α2 loop conformational landscape.

Authors:  Enrico Caldarulo; Alessandro Barducci; Kurt Wüthrich; Michele Parrinello
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-21       Impact factor: 11.205

2.  The roles of the conserved tyrosine in the β2-α2 loop of the prion protein.

Authors:  Danzhi Huang; Amedeo Caflisch
Journal:  Prion       Date:  2015       Impact factor: 3.931

3.  Asparagine and glutamine ladders promote cross-species prion conversion.

Authors:  Timothy D Kurt; Patricia Aguilar-Calvo; Lin Jiang; José A Rodriguez; Nazilla Alderson; David S Eisenberg; Christina J Sigurdson
Journal:  J Biol Chem       Date:  2017-09-20       Impact factor: 5.157

4.  Human prion protein sequence elements impede cross-species chronic wasting disease transmission.

Authors:  Timothy D Kurt; Lin Jiang; Natalia Fernández-Borges; Cyrus Bett; Jun Liu; Tom Yang; Terry R Spraker; Joaquín Castilla; David Eisenberg; Qingzhong Kong; Christina J Sigurdson
Journal:  J Clin Invest       Date:  2015-02-23       Impact factor: 14.808

Review 5.  Cross-species transmission of CWD prions.

Authors:  Timothy D Kurt; Christina J Sigurdson
Journal:  Prion       Date:  2016       Impact factor: 3.931

6.  In Vitro Approach To Identify Key Amino Acids in Low Susceptibility of Rabbit Prion Protein to Misfolding.

Authors:  Hasier Eraña; Natalia Fernández-Borges; Saioa R Elezgarai; Chafik Harrathi; Jorge M Charco; Francesca Chianini; Mark P Dagleish; Gabriel Ortega; Óscar Millet; Joaquín Castilla
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

7.  A Structural and Functional Comparison Between Infectious and Non-Infectious Autocatalytic Recombinant PrP Conformers.

Authors:  Geoffrey P Noble; Daphne W Wang; Daniel J Walsh; Justin R Barone; Michael B Miller; Koren A Nishina; Sheng Li; Surachai Supattapone
Journal:  PLoS Pathog       Date:  2015-06-30       Impact factor: 6.823

8.  Treatment of Prion Disease with Heterologous Prion Proteins.

Authors:  Pamela J Skinner; Hyeon O Kim; Damani Bryant; Nikilyn J Kinzel; Cavan Reilly; Suzette A Priola; Anne E Ward; Patricia A Goodman; Katherine Olson; Davis M Seelig
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

9.  Generic amyloidogenicity of mammalian prion proteins from species susceptible and resistant to prions.

Authors:  Sofie Nyström; Per Hammarström
Journal:  Sci Rep       Date:  2015-05-11       Impact factor: 4.379

10.  Cellular prion protein gene polymorphisms linked to differential scrapie susceptibility correlate with distinct residue connectivity between secondary structure elements.

Authors:  Patricia Soto; India A Claflin; Alyssa L Bursott; Aimee D Schwab-McCoy; Jason C Bartz
Journal:  J Biomol Struct Dyn       Date:  2020-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.